Pilots of multi-stakeholder consultations in early-stage drug development

Healthcare institutions from Europe, in October 2010, launched a new pilot process testing multi-stakeholder consultations in early-stage drug development. The purpose of the consultations is to improve clarity and alignment among the stakeholders regarding what constitutes a medicine’s value and the evidence required to demonstrate that value most effectively.